Related Experiment Video
Updated: Oct 22, 2025

Flow Cytometry Analysis of Immune Cells Within Murine Aortas
Published on: July 1, 2011
Immunity in Atherosclerosis: Focusing on T and B Cells
Anastasia V Poznyak1, Evgeny E Bezsonov2,3, Tatyana V Popkova4
1Institute for Atherosclerosis Research, Skolkovo Innovative Center, 121609 Moscow, Russia.
Insights
Inflammation and immune cells like T and B cells play key roles in atherosclerosis, a major cause of cardiovascular disease. Targeting these cells offers potential therapeutic strategies for treating this complex condition.
Area of Science:
- Cardiovascular Science
- Immunology
- Pathogenesis of Atherosclerosis
Background:
- Atherosclerosis is a primary driver of cardiovascular disease and global mortality.
- Atherogenesis involves complex processes including mitophagy, oxidative stress, endothelial damage, inflammation, and lipid metabolism alterations.
- Inflammation, particularly involving adaptive immunity cells (T and B cells), is a central component of atherogenesis.
Purpose of the Study:
- To review the role of T and B cells in the pathogenesis of atherosclerosis.
- To highlight the potential of adaptive immune cells as therapeutic targets for atherosclerosis.
Main Methods:
- Review of existing literature on the involvement of T and B cells in atherosclerosis.
- Analysis of the cellular localization and function of T and B cells within atherosclerotic lesions.
- Examination of therapeutic strategies targeting T and B cells for atherosclerosis treatment.
Main Results:
- T cells are abundant within atherosclerotic plaques.
- B cells are found in the adventitia layer of blood vessels affected by atherosclerosis.
- The presence and functions of these immune cells suggest their significant role in disease development.
- Various therapeutic approaches targeting T and B cells have been investigated.
Conclusions:
- T and B cells are integral to the inflammatory processes underlying atherosclerosis.
- Targeting adaptive immunity offers promising avenues for novel atherosclerosis therapies.
- Further research into immune cell-targeted treatments is warranted for cardiovascular disease management.
Abstract:
Atherosclerosis is the major cause of the development of cardiovascular disease, which, in turn, is one of the leading causes of mortality worldwide. From the point of view of pathogenesis, atherosclerosis is an extremely complex disease. A huge variety of processes, such as violation of mitophagy, oxidative stress, damage to the endothelium, and others, are involved in atherogenesis; however, the main components of atherogenesis are considered to be inflammation and alterations of lipid metabolism. In this review, we want to focus on inflammation, and more specifically on the cellular elements of adaptive immunity, T and B cells. It is known that various T cells are widely represented directly in atherosclerotic plaques, while B cells can be found, for example, in the adventitia layer. Of course, such widespread and well-studied cells have attracted attention as potential therapeutic targets for the treatment of atherosclerosis. Various approaches have been developed and tested for their efficacy.
Related Concept Videos
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Inflammation
Cells of the Adaptive Immune Response

